findmyKOL
Clinical trialNCT00529581CompletedPhase 2Interventional

A Study of C105 on Cognitive Dysfunction in Persons With Multiple Sclerosis

SponsorCognition Pharmaceuticals, LLCEnrollment150Cognition DisordersMultiple Sclerosis
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Saint Joseph'S Hospital, Barrow Neurology Clinics

    Phoenix, Arizona, United States

  • Northwest Neuro Specialists, Pllc

    Tuscon, Arizona, United States

  • Research Center for Clinical Studies West

    Lancaster, California, United States

  • Loma Linda University, Department of Neurology

    Loma Linda, California, United States

  • Associated Neurologists, P.C.

    Danbury, Connecticut, United States

  • Associated Neurologist of Southern Connecticut, Pc

    Fairfield, Connecticut, United States

  • Yale University Ms Center

    New Haven, Connecticut, United States

  • Neurology Associates, Pa

    Maitland, Florida, United States

  • Lovelace Scientific Resources

    Sarasota, Florida, United States

  • Roskamp Institute

    Sarasota, Florida, United States

  • Suncoast Neuroscience Associates, Inc.

    St. Petersburg, Florida, United States

  • Axiom Clinical Research of Florida

    Tampa, Florida, United States

  • Shepard Center

    Atlanta, Georgia, United States

  • University of Kansas Medical Center, Department of Neurology

    Kansas City, Kansas, United States

  • Midamerica Neuroscience Institute

    Lenexa, Kansas, United States

  • University of Kentucky

    Lexington, Kentucky, United States

  • Henry Ford Health System, Department of Neurology

    Detroit, Michigan, United States

  • Northern Michigan Neurology

    Traverse City, Michigan, United States

  • the Jacobs Neurological Institute

    Buffalo, New York, United States

  • Raleigh Neurology Associates

    Raleigh, North Carolina, United States

  • Meritcare Neuroscience Clinic

    Fargo, North Dakota, United States

  • Neurology & Neuroscience Associates, Inc.

    Akron, Ohio, United States

  • Riverhills Healthcare, Inc

    Cincinnati, Ohio, United States

  • the Neurology Foundation, Inc.

    Providence, Rhode Island, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • Central Texas Neurology

    Round Rock, Texas, United States

  • Integra Clinical Research

    San Antonio, Texas, United States

  • University of Virginia, Department of Neurology

    Charlottesville, Virginia, United States

  • Neurological Associates, Inc

    Richmond, Virginia, United States

  • Capitol Neurology

    Charleston, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2006
Primary completion
31 Mar 2008
Completion
30 Apr 2008
Last update posted
28 May 2008
Registered enrollment
150
Registry id
NCT00529581

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.